Consistently, IMPDH2 levels could discriminate the survival of adjuvant and neoadjuvant chemotherapy-treated TNBC patients (Fig. 1E), suggesting that IMPDH2 induction could be a means for cancer cells to survive/escape therapy. This evidence concerns the gene IMPDH2 and cancer.